Viatris Launches $36.50-Per-Share Cash Tender Offer for Pacira BioSciences

Viatris Inc. (VTRS) said its wholly owned subsidiary, Peach Purchaser Sub Inc., has begun a tender offer to acquire all outstanding shares of Pacira BioSciences Inc. (PCRX) for $36.50 per share in cash, under a merger agreement signed October 8, 2026. VTRS was trading at $19.11, down 0.49%; PCRX traded at $36.40, up 0.01%. After the tender offer closes, Peach Purchaser Sub is expected to merge into Pacira, which would continue as a wholly owned Viatris subsidiary. Each eligible share will convert into the right to receive $36.50 in cash, subject to withholding taxes and without interest. The deal is structured under Section 251(h) of the Delaware General Corporation Law, so no Pacira stockholder vote is required. Pacira's board unanimously recommended that shareholders tender their shares and filed its Schedule 14D-solicitation/recommendation statement with the SEC on October 30, 2026. The offer remains subject to conditions in the merger agreement and offer documents.